ClinicalTrials.gg
CompletedNCT06246058Updated Nov 18, 2024

Measuring Anticipated Attitudes and Behavior Towards a New Medical Treatment in Lesotho

An observational study in Health Behavior, Motivation and Health Care Utilization, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Lesotho. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-18.

Primary conditionPatient Acceptance of Health CareRegistry: Health BehaviorReclassifiedWhy we changed it
Registry
Health Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Patient Acceptance of Health Care
Why
  1. The study's listed conditions name Patient Acceptance of Health Care, a narrower term within Health Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Basel, Switzerland · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
475
Ages
18 Years and older
Sex
All
01

Study summary

The primary research objective is to examine how uncertainty towards a new medical treatment changes in patients when a partner (can be any close other, i.e. romantic partner, family member, or a close friend) supports the new treatment choice and is willing to be involved in the patient's treatment. I hypothesize that when the patients know that their partner supports uptake of the new medical treatment and will physically accompany them to the visit, patients will (1) experience lower levels of uncertainty and (2) report a higher likelihood of participating in a new treatment in the future, as compared to patients who face the decision about the new treatment alone.

Read the detailed description

Host trial: Uncertainty survey experiment

This study uses a survey experiment with a hypothetical scenario (vignette) to test the concept of uncertainty and the impact of partner involvement in a hypothetical new medical treatment in patients seeking healthcare in the Butha Buthe district hospital. Specifically, this host trial will be a single-blinded randomized survey experimental design. This means that there will be two versions of the vignette and participants will be randomly given only one version (1:1 allocation). The participants will not be made aware that there is a different version of the vignette but the researchers will be aware of which version the participant receives. The difference between the vignettes (called behavioral manipulation) is whether or not the partner endorses the hypothetical new medical treatment related to the patient's current illness. See the Study measures Section for the specific vignettes.

Study Within a Trial (SWAT): Impact of the researcher's attire on recruitment rates

Within the host trial, the nested study on researcher's attire will take place as a "Study Within A Trial" or SWAT. SWAT is an increasingly recognized method of research that aims to improve the research methodology within an existing trial. The SWAT on researcher attire will take place in the recruitment phase of the host experiment with day-based cluster randomization between white coat versus casual attire assignment. These attire assignments will be given along with the given week's recruitment assignments to the two Basotho research assistants who will work on the host trial. The nested study does not impact the procedures of the survey experiment. Researcher's attire during recruitment will remain the same throughout the survey delivery until the end of the participant's study visit.

02

Conditions studied

  • Health Behavior
  • Motivation
  • Health Care Utilization
  • Consumer Behavior
  • Social Behavior
  • Health Care Seeking Behavior
  • Recruitment
  • Researcher-Subject Relations

Keywords

  • Social support
  • Uncertainty
  • Low-resource setting
  • Ambiguity aversion
  • Behavioral economics
  • Research administration
  • Recruitment success
03

In context

Patient Acceptance of Health Care Reclassified

308 studies on the registry are indexed under Patient Acceptance of Health Care; 53 are open to participants now.

This study's enrollment of 475 is below the median of 583 across 80 observational studies indexed under Patient Acceptance of Health Care.

Browse Patient Acceptance of Health Care studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 990 studies on the registry; 189 are open to participants now.

Compared within Patient Acceptance of Health Care, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Health Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Recruitment will occur in the Butha Buthe district hospital and health centers in the Butha Buthe district.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults over 18 years of age
  • Are comfortable reading and writing in Sesotho or English
  • Attending as a patient in Butha Buthe-area hospital or health center for a known clinical diagnosis or standard health screening related to one of these illness categories:
  • Other sexually-transmitted infection (i.e. gonorrhea, syphilis, hepatitis)
  • Breathing problem/ tuberculosis
  • Heart issues/ blood pressure
  • Diabetes/ sugar level
  • Bone/ muscle problem
  • Mental health
  • Memory/ thinking problem
  • Teeth/ mouth problem
  • Cancer
  • Maternal health (i.e. pregnancy, post-partum care)

Exclusion criteria

Exclusion Criteria:

  • Have participated in this study before
  • Visible intoxication and/or distress, as deemed by trained research assistant
  • Unable to make independent decisions; unable to complete
  • Warrants emergency medical care
  • Visiting the hospital for another person (i.e. their child, relative, partner)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
475 participants (actual)
Patient registry
No

Groups and cohorts

  • Survey Group 1 - Support

    Receives a vignette with partner support component before answering AA-Med response items.

    Behavioral: Partner support

  • Survey Group 2 - Control

    Receives a vignette without partner support component before answering AA-Med response items.

    Behavioral: Without Partner support

  • Recruitment Group 1 - Casual

    Recruited by staff wearing casual attire.

    Behavioral: Casual recruiter attire

  • Recruitment Group 2 - Formal

    Recruited by staff wearing formal (clinical) attire

    Behavioral: Formal recruiter attire

Interventions

  • BehavioralPartner support

    The intervention group's survey vignette will include a component of partner support which serves as the key behavioral manipulation tested for this study's primary outcome.

  • BehavioralFormal recruiter attire

    The SWAT will separately test recruitment rates - as measured by rate of survey completion divided by total number of individuals approached - based on how the recruiters are dressed. FORMAL dress code of the recruiter is the intervention in this case, defined as clinical attire alluding to some clinical authority.

  • BehavioralWithout Partner support

    The intervention group's survey vignette will NOT include a component of partner support which serves as the key behavioral manipulation tested for this study's primary outcome.

  • BehavioralCasual recruiter attire

    The SWAT will separately test recruitment rates - as measured by rate of survey completion divided by total number of individuals approached - based on how the recruiters are dressed. CASUAL dress code of the recruiter is the intervention in this case.

06

What researchers measure

Primary outcomes

  1. AA-Med score

    Ambiguity aversion score difference between two survey groups; AA-Med contains 6 response items, each scored from 1 to 4 (1=disagree completely; 4=agree completely)

    Time frame: 1 time measurement immediately after intervention

Secondary outcomes

  1. Recruitment rate

    Recruitment success rate (fully participated/ approached) difference between two recruitment attire groups

    Time frame: 1 time measurement immediately after intervention

07

Study locations

1 site
  • Butha Buthe Government Hospital
    Butha Buthe, Lesotho
08

References and documents

Publications

  • Han PK, Reeve BB, Moser RP, Klein WM. Aversion to ambiguity regarding medical tests and treatments: measurement, prevalence, and relationship to sociodemographic factors. J Health Commun. 2009 Sep;14(6):556-72. doi: 10.1080/10810730903089630. PubMed 19731127 ↗

Individual participant data

Plan to share: Yes — Data obtained through this study may be provided to qualified researchers with academic interest. Data shared will be completely anonymized. Study components, aggregate data and results will be disseminated on OSF. Any additional data sharing is subject to approval of the request and execution of all applicable agreements (i.e. a material transfer agreement).

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Starting six months after completion of data collection for up to 24 months thereafter.

Access criteria: Independent researchers with academic interest.

Data sharing details ↗ · osf.io

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06246058
Collaborators
SolidarMed
Responsible party
Sponsor
First posted
Feb 7, 2024
Start date
Feb 15, 2024
Primary completion
Sep 13, 2024
Completion
Sep 13, 2024
Last update
Nov 18, 2024

Study contacts

Grace H Yoon, MSc
principal investigator · University Hospital Basel, University of Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion